The CannaBusiness Group (CBGI) Stock Analysis & Winston Score
The CannaBusiness Group, Inc. is a small company focused on cannabis-related products and services. It operates in the specialty healthcare and consumer wellness space, targeting customers who use cannabis for medical or general wellness purposes. The company works within the broader legal cannabis industry, which is still developing across the United States. The company generates revenue through product sales, though its negative gross margin suggests it currently costs more to produce goods than it earns from selling them. It appears to operate primarily in the United States, and with a market cap near zero, it is a very early-stage or micro-cap business with limited financial resources. The biggest risk facing the company is its weak financial position — negative operating margins near -86% mean it is spending far more than it brings in, and without significant improvement in sales or cost controls, it may struggle to survive long-term.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $0.00
Market Cap: $0M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
